What a fantastic six months it’s been for Masimo. Shares of the company have skyrocketed 45.8%, hitting $167.70. This was ...

The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts ...

PNC Financial Services Group Inc. boosted its stake in Masimo Co. (NASDAQ:MASI – Free Report) by 21.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...

Masimo is a leading medical technology company that specializes in noninvasive monitoring devices. It develops innovative technologies used in pulse oximetry, providing critical health metrics ...

Learn more about whether Masimo Corporation or STERIS plc is a better investment based on AAII's A+ Investor grades, which ...

Pulse oximetry is increasingly being used for remote and self-monitoring of blood oxygen in wearables, and Masimo sells a range of devices for patient monitoring purposes, including a recently ...

Notable products include Masimo’s flagship Signal Extraction Technology (SET) Pulse Oximetry, which monitors blood oxygen saturation levels and protects against hypoxemia and hyperoxemia.

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Medtronic and Masimo, two major pulse oximeter manufacturers, said they supported the FDA’s efforts but stood by their products. Samir Ibrahim, head of regulatory affairs for patient monitoring ...

IRVINE, Calif., February 28, 2025--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on ...